Concepedia

Publication | Open Access

Safety and effectiveness of FOLFOXIRI plus molecular target drug therapy for metastatic colorectal cancer: A multicenter retrospective study

DOIFull Paper Access

15

Citations

22

References

2019

Year

Takatsugu Ogata, Hironaga Satake, Misato Ogata, Yukimasa Hatachi, Hayato Maruoka, Daisuke Yamashita, Hiroki Hashida, Madoka Hamada, Hisateru Yasui
Oncotarget

Abstract

FOLFOXIRI plus antibody therapy was effective in patients with mCRC. The response rate was higher in patients treated with anti-EGFR antibodies than in those treated with anti-VEGF antibodies.

References

YearCitations

Page 1